This review summarizes the current literature regarding the effects of testosterone therapy (TTh) on common disorders of the prostate.
Testosterone therapy has gained credibility over the last several decades as a potentially safe co-treatment modality for men with benign and malignant prostatic conditions. Our understanding of the effects of testosterone on the prostate continues to evolve with ongoing clinical and basic science research. Findings of these studies have reinvigorated the debate over the effects of testosterone on benign and malignant disorders of the prostate, including BPH, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and prostate cancer.
Despite the burgeoning body of data claiming the safety and efficacy of TTh in common prostatic conditions (including BPH, CP/CPPS, and prostate cancer), diligent monitoring, appropriate patient selection, and informed consent are critical until more definitive studies are performed.
Current sexual health reports. 2017 Apr 26 [Epub]
Amin S Herati, Taylor P Kohn, Peter R Butler, Larry I Lipshultz
Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030., Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030.